Search

Your search keyword '"Hashem, Hebatalla S."' showing total 3 results
Start Over Author "Hashem, Hebatalla S." Language english
3 results on '"Hashem, Hebatalla S."'

2. Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy

Author

Novarino, Gaia, El-Fishawy, Paul, Kayserili, Hulya, Meguid, Nagwa A., Scott, Eric M., Schroth, Jana, Silhavy, Jennifer L., Kara, Majdi, Khalil, Rehab O., Ben-Omran, Tawfeg, Ercan-Sencicek, A. Gulhan, Hashish, Adel F., Sanders, Stephan J., Gupta, Abha R., Hashem, Hebatalla S., Matern, Dietrich, Gabriel, Stacey, Sweetman, Larry, Rahimi, Yasmeen, Harris, Robert A., State, Matthew W., and Gleeson, Joseph G.

Published
2012
Full Text
View/download PDF

3. Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy.

Author

Novanno, Gala, El.-Fishawy, Paul, Kayseriti, Hulya, Meguid, Nagwa A., Scott, Eric M., Schroth, Jana, Silhavy, Jennifer L., Kara, Majdi, Khalil, Rehab O., Ben.-Omran, Tawfeg, Ercan.-Sencicek, A. Gulhan, Hashish, Adel F., Sanders, Stephan J., Gupta, Abha R., Hashem, Hebatalla S., Matern, Dietrich, Gabriel, Stacey, Sweetman, Larry, Rahimi, Yasmeen, and Harris, Robert A.

Subjects
*MEDICAL genetics, *AUTISM, *AUTISM spectrum disorders, *SOCIAL interaction, *GENETIC mutation, *PEOPLE with epilepsy, *GENETIC disorders, *RNA, *BRANCHED chain amino acids, *PATIENTS, TREATMENT of developmental disabilities
Abstract

Autism spectrum disorders are a genetically heterogeneous constellation of syndromes characterized by impairments in reciprocal social interaction. Available somatic treatments have limited efficacy. We have identified inactivating mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous fatuities with autism, epilepsy, and intellectual disability. The encoded protein is responsible for phosphorylation-mediated inactivation of the E1α subunit of branched-chain ketoacid dehydrogenase (BCKDH). Patients with homozygous BCKDK mutations display reductions in BCKDK messenger RNA and protein, E1α phosphorylation, and plasma branched-chain amino acids. Bckdk knockout mice show abnormal brain amino acid profiles and neurobehavioral deficits that respond to dietary supplementation. Thus, autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome. [ABSTRACT FROM AUTHOR]

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results